Commission Implementing Regulation (EU) 2021/2068 [Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 421, 26.11.2021, p. 25).] extended the approval period of the active substance dimoxystrobin until 31 January 2023.
Recital 2, Regulation (EU) 2023/115
In forcesince 16 Jan 2023